MLLT4

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA030212

Antibody HPA030213

Antibody HPA030214

Antibody HPA030215

Antibody CAB013496

Tissue

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most of the malignant cells displayed weak to moderate cytoplasmic positivity accompanied with membranous immunoreactivity. A majority of malignant gliomas, lymphomas and melanomas as well as renal cancers were negative.A majority of malignant cells displayed weak to moderate cytoplasmic and membranous immunoreactivity. Several cases of endometrial, testicular and pancreatic cancers exhibited strong positivity. Most of the malignant cells displayed weak to moderate cytoplasmic positivity. Most malignant lymphomas, prostate and renal caners as well as several hepatocellular carcinomas were negative.Most malignant cells displayed moderate to strong cytoplasmic staining, often with a granular pattern. Strongest positivity was observed in endometrial, pancreatic and liver cancers.Several cases of malignant gliomas, testicular and renal cancers showed moderate cytoplasmic immunoreactivity. Remaining malignant cells were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected